Company Filing History:
Years Active: 2023-2024
Title: Innovations of Eugene E Marcantonio
Introduction
Eugene E Marcantonio is a notable inventor based in Tenafly, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that target ryanodine receptors. With a total of three patents to his name, Marcantonio's work is paving the way for advancements in medical treatments.
Latest Patents
Marcantonio's latest patents focus on pharmaceutical compositions comprising a ryanodine receptor modulator. These modified-release pharmaceutical compositions include 4-[(7-methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)yl)methyl]benzoic acid hemifumarate, along with a pharmaceutically-acceptable excipient. The methods disclosed in these patents aim to treat various conditions associated with ryanodine receptors, including cardiac disorders, musculoskeletal diseases, cancer-associated muscle weakness, malignant hyperthermia, and diabetes.
Career Highlights
Eugene E Marcantonio is currently associated with Armgo Pharma, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in ryanodine receptor modulation has positioned him as a key player in developing new therapeutic strategies.
Collaborations
Marcantonio collaborates with talented professionals in his field, including Mette Uhre Anby and Jérôme Binet. These partnerships enhance the research and development efforts at Armgo Pharma, Inc.
Conclusion
Eugene E Marcantonio's contributions to pharmaceutical innovations demonstrate his commitment to improving medical treatments through his patented inventions. His work continues to impact the field positively, showcasing the importance of innovation in healthcare.